Causeway Therapeutics Secures £8.75M for Phase 2 Trial of Tendinopathy Therapy
University of Glasgow spin-out will use funds to advance development of microRNA therapeutics Causeway Therapeutics, a University of Glasgow spin-out specializing in tendon disease has raised £8.75M from investors to […]